Sign in
Evaluation of Baseline Characteristics on Lesion Progression in a Large Phase 2 Clinical Trial for Geographic Atrophy (FILLY Study)
Eleonora Lad, MD, PhD
Annual Meeting Talks
2019
Safety and Efficacy of SC Elamipretide to Treat Noncentral Geographic Atrophy: ReCLAIM-1 Results and Phase II ReCLAIM-2 Baseline Characteristics
David R Lally, MD
2021
Interview Reversal of Retinal Ischemia After Anti-VEGF Therapy
Thomas R. Friberg, MD
Updates from the Field
Category: Age-Related Macular Degeneration